Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709173 · ClinicalTrials.gov registry record
FuRST 2.0 Cognitive Pre-testing - Round 2
A clinical trial, sponsored by CHDI Foundation.
- Completed
- Registry status
- 52
- Enrollment target
NCT03709173 is a clinical trial that has completed, run by CHDI Foundation. The registered enrollment target is 52 participants.
The verdict
NCT03709173 has completed, sponsored by CHDI Foundation.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The study is a single, cross-sectional cognitive interview of FuRST 2.0, functional rating scale, administered to forty Huntington's Disease Gene Expansion Carriers (HDGECs) and potentially, their companions (the companion's participation is optional in this study). The scale will be tested as a patient reported outcome (PRO) in that the information will come directly from the HDGEC participant or the HDGEC participant together with his/her companion through self-report. The purpose is to identify real or potential comprehension or usage problems with scale items, response options, instructions and disclaimer statement, which are all components of the FuRST 2.0 scale. Through a structured cognitive interview with the HDGEC participants or the HDGEC participants together with their companions, followed by qualitative analysis, the final phrasing of the individual scale items, response options, instructions and disclaimer statement for the scale will be generated. Depending on the results of this study, an additional round of cognitive pre-testing may be required in a separate study.
Interventions
- BEHAVIORAL FuRST 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2019-08-02 |
| Est. Completion | 2019-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709173
The ClinicalTrials.gov registry entry for NCT03709173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CHDI Foundation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FuRST 2.0 is the first listed.
NCT03709173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03709173 about?
NCT03709173 is a clinical study titled "FuRST 2.0 Cognitive Pre-testing - Round 2". The study is a single, cross-sectional cognitive interview of FuRST 2.0, functional rating scale, administered to forty Huntington's Disease Gene Expansion Carriers (HDGECs) and potentially, their companions (the companion's participation is optional in this study). The scale will be tested as a pat...
What is the current status of trial NCT03709173?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2019-08-02. Estimated completion is 2019-10-25.
What interventions are being tested in trial NCT03709173?
The interventions under investigation include: FuRST 2.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03709173?
This trial is sponsored by CHDI Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.